NRP1 and neoplasm: Moreover, recently Gioelli et al. showed that a modified SEMA3A devoid of NRP1-binding can effectively inhibit tumor growth and metastatic dissemination via PlexinA4 [33], expressed in both tumor vessels and immune cells.